Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities
Abstract The use of anti-cancer adjuvant therapy is rationalized by potentiating the efficacy, and/or protecting from major side effects of chemotherapeutics. Thymoquinone (TQ) is a naturally occurring compound with cumulative evidence of anti-cancer properties. In this study, we assessed the chemom...
Main Authors: | Hanan A. Bashmail, Aliaa A. Alamoudi, Abdulwahab Noorwali, Gehan A. Hegazy, Ghada AJabnoor, Hani Choudhry, Ahmed M. Al-Abd |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2018-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-018-30046-z |
Similar Items
-
Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism
by: Hanan A. Bashmail, et al.
Published: (2020-01-01) -
Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells
by: Rinad A. Algehani, et al.
Published: (2021-08-01) -
The synergism of Clinacanthus nutans Lindau extracts with gemcitabine: downregulation of anti-apoptotic markers in squamous pancreatic ductal adenocarcinoma
by: Ling-Wei Hii, et al.
Published: (2019-09-01) -
Autophagic and Apoptotic Pathways as Targets for Chemotherapy in Glioblastoma
by: Cristina Trejo-Solís, et al.
Published: (2018-11-01) -
HDAC and Proteasome Inhibitors Synergize to Activate Pro-Apoptotic Factors in Synovial Sarcoma.
by: Aimée N Laporte, et al.
Published: (2017-01-01)